• Email
  • Print
  • Share
  • Text
Highlight Glossary Terms
  • Report from the 2011 San Antonio Breast Cancer Symposium
  • 4:53
  • Harold Burstein, MD, PhD, provides an overview of the latest in breast cancer research presented at the 2011 San Antonio Breast Cancer Symposium, including findings of the CLEOPATRA trial, which looked at combining pertuzumab with trastuzumab and docetaxel in women with metastatic HER2-positive disease; the BOLERO-2 trial, which focused on combining everolimus and exemestane in women with metastatic breast cancer; and the controversy surrounding the effectiveness of osteoporosis drugs in preventing breast cancer.

Tags: BreastCancer